Search filters

List of works by Mark J. Federspiel

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice ⬇️

scientific article published on November 1, 2003

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

scientific article published on 22 February 2017

Comparative oncology evaluation of intravenous recombinant oncolytic Vesicular Stomatitis Virus therapy in spontaneous canine cancer

scientific article published on 20 November 2017

Correction for Tesfay et al., Vesiculovirus Neutralization by Natural IgM and Complement.

scientific article published on 12 January 2015

Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter

scientific article published on March 2006

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

scientific article published in December 2006

Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus

scientific article

Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters

scientific article

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

scientific article published on 22 June 2019

Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer

scientific article published on 01 July 2005

Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer

scientific article

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

scientific article

Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer

scientific article published on 24 January 2013

PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice

scientific article published on 16 January 2013

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

scientific article

Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck

scientific article published on February 2014

Remission of disseminated cancer after systemic oncolytic virotherapy

scientific article

Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy

scientific article published on 10 December 2014

Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model

scientific article published on 27 September 2016

Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS.

scientific article

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

scientific article published in April 2010

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs

scientific article

Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.

scientific article

Vesiculovirus neutralization by natural IgM and complement

scientific article published on 19 March 2014

Paulina is supported by:

About Paulina

Help